Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
GM Food Goes on Trial
Corporate Accountability and WorkPlace:
Rolling Stone Expose Declares Goldman Sachs Behind Every Market Crash Since 1920s
Daniel Tencer
DrugReporter:
Michael Jackson Probably O.D.'d -- Just Like Thousands of Americans Who Fall Victim to Our Overdose Epidemic
Jill Harris
Environment:
Michael Pollan: We Are Headed Toward a Breakdown in Our Food System
David Beers
Health and Wellness:
Labor Rallies for Health Care, But Keeps it Vague
Jane Slaughter
Immigration:
Why is the Government Criminalizing Humanitarian Aid at the U.S.-Mexico Border?
Valeria Fernandez
Media and Technology:
Will the Tragedy of Michael Jackson's Life Be Inherited By His Kids?
Patricia J. Williams
Movie Mix:
This Time, Pixar Has Gone Too Far
Eileen Jones
Politics:
Breadline USA: Why People Are Going Hungry in the Land of Plenty
Sasha Abramsky
Reproductive Justice and Gender:
Why Are People Obsessed with Their Kids?
Vanessa Richmond
Rights and Liberties:
In Iran, Fears That a Prominent Prisoner Detained In Election Upheaval Could Die in Jail
Katie Mattern
Sex and Relationships:
Why the Left Looks Like a Big Hypocrite in the Sanford Affair
JoAnn Wypijewski
Take Action:
Pressuring Obama to Make the Right Decision on Health Care is AlterNet's Top Campaign of the Week
Byard Duncan
Water:
David v. Goliath: Help Michigan Citizens Protect Their Water from Nestle's Bottling Operations
Leslie Samuelrich
World:
High Noon in Honduras
Laura Carlsen
The fundamental rule of retail is: The consumer is always right. The World Trade Organization (WTO) has once again disregarded this rule by declaring the majority of European consumers wrong.
In poll after poll, Europeans have voiced their skepticism of food that's been altered at the genetic level. Their governments initially responded with a moratorium on new GM products and subsequently adopted a Europe-wide policy on product labeling. But in its latest ruling, the WTO did some labeling of its own, declaring Europe's cautious policy on genetically modified organisms (GMO) an unfair barrier to trade.
The 800-page report, the longest decision in the WTO's short history, has not yet been released to the public. But the U.S. government and its co-plaintiffs, Canada and Argentina, are already treating it as a historic ruling. The European Union, on the other hand, has dismissed the report as simply a ruling about history, since it lifted its moratorium against GMOs in 2004. Still unclear is how the ruling will affect different regions within Europe that continue to declare themselves GM-free.
The Europeans will likely appeal the ruling. If it still goes against them, they may well steal a page from their other longstanding dispute with the United States over hormones in beef: Pay the penalty and maintain the cautious policy.
What's the big deal? you might ask. They say tomato and we say GM tomato, so let's forget about the whole thing. But the United States has been downright pushy in its approach to biotech. The Agency for International Development (AID) is a big booster of GM, and some offending grain has found its way into shipments of food aid to GM-wary countries. The Trade Representative's office pushes GM through bilateral and multilateral treaties. The State Department tries to twist arms through rather undiplomatic letters of protest, like the one it sent to Nicosia in July when new EU member Cyprus proposed to put GM food on separate shelves at grocery stores.
This pushiness is not simply a byproduct of the usual missionary arrogance of Americans. The underlying story is that biotech has hit a few roadblocks.
In 2005, according to the International Service for the Acquisition of Agri-biotech Applications, the rate of growth of GM crops was 11 percent. That might seem like a lot. But it's the slowest growth rate since GM was introduced in the mid-1990s. The rate is down from 20 percent in 2004 and 15 percent in 2003. Even taking into account the saturation of certain markets -- GM soy, for instance, now accounts for 85 percent of the soybeans grown in the United States -- such a slowdown translates into lost revenue for biotech firms and less buzz for the movement as a whole.
Governments around the world remain circumspect. Even China, which has moved quickly on some GM crops like cotton, recently stepped back from commercializing GM rice in November, citing safety concerns.
John Feffer is working on a book about the global politics of food.
Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »